Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study von Yang, Kaili, Han, Lu, Wu, Shikai, Qu, Xiujuan, Li, Qin, Zhao, Chuanhua, Zhou, Jing, Jin, Xuan, Wang, Yusheng, Yan, Dong, Cheng, Zhiqiang, Hua, Yuwei, Zhang, Yan, Ge, Yang, Sun, Jinghua, Deng, Wei, Zhao, Lin, Zhao, Yunbo

Volltext

A combined immune prognostic index in esophageal squamous cell carcinoma patients treated with anti-PD-1 therapy von Ji, Shoujian, Zhao, Chuanhua, Liu, Rongrui, Wang, Yan, Yang, Qing, Yang, Hua, Xu, Jianming

Volltext

Identification of immune checkpoint and cytokine signatures associated with the response to immune checkpoint blockade in gastrointestinal cancers von Zhao, Chuanhua, Wu, Lihong, Liang, Dandan, Chen, Huan, Ji, Shoujian, Zhang, Guanxiong, Yang, Keyan, Hu, Ying, Mao, Beibei, Liu, Tianshu, Yu, Yiyi, Zhang, Henghui, Xu, Jianming

Volltext

A region-resolved mucosa proteome of the human stomach von Ni, Xiaotian, Tan, Zhaoli, Ding, Chen, Zhang, Chunchao, Song, Lan, Yang, Shuai, Liu, Mingwei, Jia, Ru, Zhao, Chuanhua, Song, Lei, Liu, Wanlin, Zhou, Quan, Gong, Tongqing, Li, Xianju, Tai, Yanhong, Zhu, Weimin, Shi, Tieliu, Wang, Yi, Xu, Jianming, Zhen, Bei, Qin, Jun

Volltext

Larotinib in patients with advanced and previously treated esophageal squamous cell carcinoma with epidermal growth factor receptor overexpression or amplification: an open-label,... von Liu, Rongrui, Liu, Lianke, Zhao, Chuanhua, Bai, Yuxian, Zheng, Yulong, Zhang, Shu, Li, Ning, Yang, Jianwei, Fan, Qingxia, Wang, Xiuwen, Zeng, Shan, Zhang, Yingjun, Zhang, Weihong, Zhuang, Yulei, Kang, Ning, Jiang, Yingzhi, Sun, Hongmei, Xu, Jianming

Volltext

Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumors von Li, Huiping, Liu, Rongrui, Shao, Bin, Ran, Ran, Song, Guohong, Wang, Ke, Shi, Yehui, Liu, Jihong, Hu, Wenjing, Chen, Fu, Liu, Xiaoran, Zhang, Gairong, Zhao, Chuanhua, Jia, Ru, Wang, Quanren, Rugo, Hope S, Zhang, Yifan, Li, Guangze, Xu, Jianming

Volltext

Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion... von Xu, Jianming, Zhang, Yun, Jia, Ru, Yue, Chunyan, Chang, Lianpeng, Liu, Rongrui, Zhang, Gairong, Zhao, Chuanhua, Zhang, Yaoyue, Chen, Chunxia, Wang, Yan, Yi, Xin, Hu, Zhiyuan, Zou, Jianjun, Wang, Quanren

Volltext

The novel HLA‐B51:389 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual von Lou, Xiao, Zhao, Chuanhua, An, Lin, Yu, Changlin, Guo, Mei

Volltext

Two neurosubtypes of ADHD different from the clinical phenotypes von Wang, Qi, Zhao, Chuanhua, Qiu, Jianfeng, Lu, Weizhao

Volltext

Assessment of PD‐L1 Expression on Circulating Tumor Cells for Predicting Clinical Outcomes in Patients with Cancer Receiving PD‐1/PD‐L1 Blockade Therapies von Tan, Zhaoli, Yue, Chunyan, Ji, Shoujian, Zhao, Chuanhua, Jia, Ru, Zhang, Yun, Liu, Rongrui, Li, Da, Yu, Qian, Li, Ping, Hu, Zhiyuan, Yang, Yanlian, Xu, Jianming

Volltext

Unrelated donor umbilical cord blood transplant versus unrelated hematopoietic stem cell transplant in patients with acute leukemia: A meta-analysis and systematic review von Lou, Xiao, Zhao, Chuanhua, Chen, Hu

Volltext

DNA in serum extracellular vesicles is stable under different storage conditions von Jin, Yang, Chen, Keyan, Wang, Zongying, Wang, Yan, Liu, Jianzhi, Lin, Li, Shao, Yong, Gao, Lihua, Yin, Huihui, Cui, Cong, Tan, Zhaoli, Liu, Liejun, Zhao, Chuanhua, Zhang, Gairong, Jia, Ru, Du, Lijuan, Chen, Yuling, Liu, Rongrui, Xu, Jianming, Hu, Xianwen, Wang, Youliang

Volltext

Preliminary results of a phase I, first-in-human, dose escalation study of IMM2902 in patients with HER2-expressing advanced solid tumors von Meng, Yanchun, Zhang, Jian, Zhao, Chuanhua, Cheng, Ying, Zhu, Liming, Song, Zhengbo, Xu, Nong, Wang, Zhen, Wang, Yanping, Du, Yiqun, Jing, Deqiang, Chen, Dinglu, Qu, Qiaofeng, Zhao, Xiwen, Li, Wei, Lu, Qiying, Tian, Wenzhi, Xu, Jianming

Volltext

Regorafenib plus PD-1 inhibitors in Chinese patients with microsatellite stable/mismatch repair proficient metastatic colorectal cancer: A real-world study von Yang, Kaili, Han, Lu, Zhao, Yun-Bo, Ge, Yang, LI, Qin, Wang, Yusheng, Wu, Shikai, Zhang, Yan, Zhao, Chuanhua, Zhou, Jing, Zhao, Lin

Volltext

Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer von Wang, Yan, Zhao, Chuanhua, Chang, Lianpeng, Jia, Ru, Liu, Rongrui, Zhang, Yun, Gao, Xuan, Li, Jin, Chen, Rongrong, Xia, Xuefeng, Bulbul, Ajaz, Husain, Hatim, Guan, Yanfang, Yi, Xin, Xu, Jianming

Volltext

A first-in-human phase 1a trial of sintilimab (IBI308), a monoclonal antibody targeting programmed death-1 (PD-1), in Chinese patients with advanced solid tumors von Xu, Jian-Ming, Jia, Ru, Wang, Yan, Liu, Rongrui, Zhao, Chuanhua, Zhou, Hui, Xu, Linxinyu, Kong, Xuan

Volltext

Postradiation ctDNA status as a prognostic factor in locally advanced esophageal squamous cell carcinoma von Jia, Ru, Li, Pansong, Zhao, Chuanhua, Wang, Yan, Liu, Rongrui, Chang, Lianpeng, Guan, Yanfang, Yi, Xin, Xu, Jian-Ming

Volltext

A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma von Zhao, Chuanhua, Lin, Li, Liu, Jianzhi, Liu, Rongrui, Chen, Yuling, Ge, Feijiao, Jia, Ru, Jin, Yang, Wang, Yan, Xu, Jianming

Volltext

Association of co-occuring mutations in exosomal DNA and clinical outcomes of patients with metastatic colorectal cancer von Zhao, Chuanhua, Chang, Lianpeng, Cui, Cong, Tan, Zhaoli, Jia, Ru, Wang, Yan, Liu, Rongrui, Zhang, Yun, Liu, Jianzhi, Xu, Jian-Ming

Volltext

Anti-programmed death-1 antibody SHR-1210 (S) combined with apatinib (A) for advanced hepatocellular carcinoma (HCC), gastric cancer (GC) or esophagogastric junction (EGJ) cancer r... von Xu, Jian-Ming, Zhang, Yun, Jia, Ru, Wang, Yan, Liu, Rongrui, Zhang, Gairong, Zhao, Chuanhua, Zhang, Yaoyue, Zou, Jianjun, Wang, Quanren

Volltext